Osteoporosis International

Article	Citations
Dual-energy x-ray absorptiometry scanner mismatch in follow-up bone mineral density testing	721
Comment on “Rebound hypercalcemia post-denosumab cessation in metastatic breast cancer”: Waxing-Waning Serum Calcium following Denosumab use in a patient with Polyostotic Paget’s Disease of Bone	282
RE: “Race/ethnic differences in trabecular bone score in mid-life women: the Study of Women’s Health Across the Nation (SWAN)”	90
Response to letter, re. “Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data”	85
Incident peptic ulcers and concomitant treatment of direct oral anticoagulants and oral bisphosphonates—a real-world cohort study	81
Mineral-rich water consumption as a non-pharmacological intervention for early menopausal bone mineral density preservation and reduction of long-term fracture risk: comment on Billington et al. Osteo	76
A promising strategy for the diagnosis, treatment, and prevention of osteoporosis (EMS strategy)	75
One versus 2 years of alendronate following denosumab: the CARD extension	60
Correction to: Author response to the comments on our article Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture pat	56
The clinical trial landscape of anti-RANKL agents for osteoporosis: current status and future directions	54
The association between blood cadmium levels and bone mineral density in U.S. adolescents aged 12–19 years	52
The effects of β-carotene on osteoporosis: a systematic review and meta-analysis of observational studies	46
Impact of the guidance on fracture Liaison Services and the introduction of a new fee for secondary fracture prevention in Japan: Implementation of secondary fracture prevention during hospitalization	46
RETRACTED ARTICLE: Evaluation of bone mineral density (BMD) and trabecular bone score (TBS) in pheochromocytoma and paraganglioma; a multi-centric case–control study from India	45
Comparison of the efficacy between sequential therapy with teriparatide and denosumab and denosumab monotherapy in suppressing fragility fracture risk	40
Changes in spinal sagittal balance after a new osteoporotic vertebral compression fracture	40
Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study	39
Epidemiology of pelvic and acetabular fractures in the USA from 2007 to 2014	39
Scaffolds: a biomaterial engineering in targeted drug delivery for osteoporosis	37
The incidence of subsequent contralateral hip fracture and factors associated with increased risk: the IMPACT Contralateral Fracture Study	36
Follicle-stimulating hormone is associated with low bone mass in postmenopausal women	35
Return on investment of fracture liaison services: a systematic review and analysis	34
The link between osteoporosis and cardiovascular diseases: a review of shared mechanisms, risk factors, and therapeutic approaches	34
Association between body mass index, bone bending strength, and BMD in young sedentary women	34
Artificial intelligence insights into osteoporosis: comment	33

Author response to: Comment from Dongdong Cao, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nati	32
Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study	32
Evaluating the impact of COVID-19 on DXA waiting lists and osteoporosis prescription trends in England 2019–2023	32
Bisphosphonate drug holidays in osteoporosis according to fracture risk profile	31
Patients not taking a previously prescribed bone active medication now prescribed medication through Ontario FLS	29
Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosis	29
An LRP6 mutation (Arg360His) associated with low bone mineral density but not cardiovascular events in a Caucasian family	29
Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naïve patients: two further cases	27
Latent metabolic bone disease, skeletal dysplasia and other conditions related to low bone formation among 38 patients with subtrochanteric femoral fractures: a retrospective observational study	27
Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project	27
Adjusting conventional FRAX estimates of fracture probability according to the number of prior falls in the preceding year	26
A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis	25
Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture	24
Updated trabecular bone score accounting for the soft tissue thickness (TBSTT) demonstrated significantly improved bone microstructure with denosumab in the FREEDOM TBS post hoc analysis	23
International consensus on the non-pharmacological and non-surgical management of osteoporotic vertebral fractures	23
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ESPRM-ESCEO-IOF Symposium Abstracts	23
Comparison of pharmacokinetics, pharmacodynamics, safety, and immunogenicity of teriparatide biosimilar with EU- and US-approved teriparatide reference products in healthy men and postmenopausal women	23
Opportunistic measures of bone mineral density at multiple skeletal sites during whole-body CT in polytrauma patients	23
Romosozumab and antiresorptive treatment: the importance of treatment sequence	23
Author response to OSIN-D-23–00510, “Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients re	22
Correction to: Response to letter, re. “Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data”	22
Correction to: Secular trends of incidence and hospitalization cost of hip fracture in Tangshan, China	22
The importance of structural barriers of osteoporotic hip fracture in the elderly	22
Correction: Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care	21
Denosumab and clinical outcomes among men with osteoporosis: a retrospective cohort study	21
Characterizing types and circumstances of fractures in the Canadian Multicentre Osteoporosis Study	21
Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis	21
Comment on: The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis	21
Fracture liaison service evaluation during admission for fragility femur fracture increases rates of bone health intervention and outpatient follow-up	20
Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study	20
Short- and long-term prognostic factors associated with functional recovery in elderly patients with hip fracture: A systematic review	20
Causal relationship between type 2 diabetes mellitus and bone mineral density: a Mendelian randomization study in an East Asian population	19
Twenty-four months of follow-up in women with rebound-associated vertebral fractures after discontinuation of denosumab: a single-centre case series	19
Does exercise affect bone mineral density and content when added to a calorie-restricted diet? A systematic review and meta-analysis of controlled clinical trials	19
Comorbidity and risk of infection among patients with hip fracture: a Danish population-based cohort study	19
Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review	19
Insulin resistance, bone health, and fracture risk	19
Fracture risk following bariatric surgery: a systematic review and meta-analysis	19
Correction: PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis	19
Effects of microplastics on the bones: a comprehensive review	19
Temporal trends in socioeconomic inequalities and risk of infection after hip fracture surgery: a nationwide cohort study, 2010–2021	18
Semi-automatic proximal humeral trabecular bone density assessment tool: technique application and clinical validation	18
Opportunistic osteoporosis screening using chest CT with artificial intelligence	18
Zoledronic acid–induced severe lymphopenia	18
Joint association of milk intake and blood 25(OH)D levels with fracture risk in postmenopausal women: 20-year follow-up data from the Japanese Population-Based Osteoporosis cohort study	18
Imaging of pelvic ring fractures in older adults and its clinical implications-a systematic review	18
The association between lumbar paraspinal muscle functional cross-sectional area on MRI and regional volumetric bone mineral density measured by quantitative computed tomography	17
Letter to the Editor regarding “Associations between ultra-distal forearm bone mineral density and incident fracture in women”	17
Proposed bone health screening protocol to identify total knee arthroplasty patients for preoperative DXA	17
The association of coffee consumption with the risk of osteoporosis and fractures: a systematic review and meta-analysis	17

The association of frailty with clinical and economic outcomes among hospitalized older adults with hip fracture surgery	16
Development and validation of a prediction model for falls among older people using community-based data	16
Author response to OSIN-D-24–00958 comment on: the association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis	16
Correction to: Determination of the combined effects of asian herbal medicine with calcium and/or vitamin D supplements on bone mineral density in primary osteoporosis: A systematic review and meta-an	16
Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study.	16
Response to: “Zoledronate-induced acute anterior uveitis: a three-case report and brief review of literature”	16
Letter of rebuttal to ‘Comment on: Imaging of pelvic ring fractures in older adults and its clinical implications—a systematic review’	16
Correction to: Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care	16
A novel fracture liaison service using digital health: impact on mortality in hospitalized elderly osteoporotic fracture patients	15
Correction: determination of the combined effects of asian herbal medicine with calcium and/or vitamin D supplements on bone mineral density in primary osteoporosis: a systematic review and meta-analy	15
Impact of the COVID-19 pandemic on osteoporotic hip fractures among outpatients in Germany	15
Comment on “Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005–2018”	15
A tribute to Uri A. Liberman, 1935–2022	15
Risk factors for hip fracture	15
Osteoporotic vertebral fractures localized in the lumbar area significantly impact sagittal alignment	15
Nrf2 signaling pathway: focus on oxidative stress in osteoporosis	15
Beneficial effects of denosumab on muscle performance in patients with low BMD: a retrospective, propensity score-matched study	15
Association between osteoporosis and risk of dementia: a Korean women nationwide population-based cohort study	15
Error in Mendelian randomization analysis in “Higher risk of osteoporosis in adult-onset asthma than childhood-onset asthma”	15
Prevalence of low bone mineral density (T-score ≤  − 2.5) in the whole spectrum of chronic kidney disease: a systematic review and meta-analysis	15
Authors’ response to 01460, renal dysfunction and its influence on osteoporosis treatment outcomes: a critical review of recent findings	15
A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients	15
Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk	15
Mortality among older adults with osteoporotic vertebral fracture	15
Costs of incident non-hip osteoporosis-related fractures in postmenopausal women from a payer perspective	15
Prior fragility fractures are associated with a higher risk of 8-year complications following total shoulder arthroplasty	15
Effects of non-supervised exercise interventions on bone mineral density in adult women: a systematic review and meta‑analysis	15
Correction to: Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study	15
Standardization of the nomenclature of bone status indices: a milestone in diagnostic consistency and clarity	15
Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis	15
Bone mineral density and lipid profiles in older adults: a nationwide cross-sectional study	15
Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment	15
Baseline serum PINP level is associated with the increase in hip bone mineral density seen with Romosozumab treatment in previously untreated women with osteoporosis	15
A longitudinal genome-wide association study of bone mineral density mean and variability in the UK Biobank	15
Bone, cognitive, and anthropometric profiles and their relation to fracture sites in fallers: a cross-sectional study	15
Author Response to OSIN-D-24–00437: Letter to the Editor regarding “Associations between ultra-distal forearm bone mineral density and incident fracture in women”	14
Comment on Byun et al.: The effect of teriparatide on fracture healing after atypical femoral fracture: a systematic review and meta-analysis	14
Trabecular bone score in PODA, a Randomized Controlled Trial (RCT) in older African American Women	14
Prevalence of osteoporosis in older male veterans receiving hip-containing computed tomography scans: opportunistic use of biomechanical computed tomography analysis (BCT)	14
Letter to the editor concerning “Sex differences in hemoglobin levels and five-year refracture risk in patients with osteoporotic fractures: a retrospective cohort analysis”	14
Fragility fracture and fear of falling in middle aged adults-a prevalence study	14
Metabolic factors associated with incident fracture among older adults with type 2 diabetes mellitus: a nested case–control study	14
Birth weight and birth length affect future fracture risk differently in men and women	14
RE: Clinical features of fallers and non-fallers: Finding best-performing combinations of physical performance measurements to discriminate physical impairments between fallers and non-fallers among o	14
The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture—results of a large observational cohort study	14
Delayed and significant hypercalcaemia due to teriparatide therapy: a case report and review	13
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthrit	13
The hip fracture incidence in the high-risk area Oslo continues to decline	13
Prolonged hypercalcemia induced by teriparatide: a case report and literature review	13
Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group	13
Skeletal health status among patients with chronic hypoparathyroidism: results from the Canadian National Hypoparathyroidism Registry (CNHR)	13
MR-based proton density fat fraction (PDFF) of the vertebral bone marrow differentiates between patients with and without osteoporotic vertebral fractures	13
Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41	13
Prediabetes and insulin resistance are associated with lower trabecular bone score (TBS): cross-sectional results from the Study of Women’s Health Across the Nation TBS Study	13
Milk intake and hip fracture incidence in community-dwelling old Icelandic adults	13
The effect of starting metformin on bone mineral density among women with type 2 diabetes in the Study of Women’s Health Across the Nation (SWAN)	13
Group-based trajectories of potentially preventable hospitalisations among older adults after a hip fracture	13
Opportunistic use of lumbar computed tomography and magnetic resonance imaging for osteoporosis screening	13
Biochemical and clinical manifestations in adults with hypophosphatasia: a national cross-sectional study	13
Effects of different exercise intensity on bone mineral density in adults: a comparative systematic review and meta-analysis	13
Lower limb bone geometry in adult individuals with X-linked hypophosphatemia: an observational study	13
Fracture risks in patients aged 50 years and older with panhypopituitarism: a nationwide cohort study	13
Demographics and medical burden of osteogenesis imperfecta: a nationwide database analysis	12
Focal dermal hypoplasia: a probable underrecognized low bone mass disorder secondary to aberrant Wnt signaling	12
Discontinuation of denosumab in men with prostate cancer	12
The Geriatrics at Risk Score (GeRi-Score) for mortality prediction in geriatric patients with proximal femur fracture – a development and validation study from the Registry for Geriatric Trauma (ATR-D	12
Osteoporosis in older patients with idiopathic normal pressure hydrocephalus	12
The high-risk hip fracture patient and the palliative care consult	12
Prognosis and institutionalization of frail community-dwelling older patients following a proximal femoral fracture: a multicenter retrospective cohort study	12
Author response to: OSIN-D-24–00381, artificial intelligence insights into osteoporosis	12
Improving the reporting of economic evaluation in osteoporosis: the value of CHEERS 2022 statement	12
Effects of combined protein and exercise interventions on bone health in middle-aged and older adults — A systematic literature review and meta-analysis of randomized controlled trials	12
Thirty years of hip fracture incidence in Austria: is the worst over?	12
Rheumatoid arthritis and osteogenesis imperfecta: is there a genetic causal association?	12
Long-term clinical and socio-economic outcomes following wrist fracture: a systematic review and meta-analysis	12
Atypical periprosthetic femoral fracture with stem breakage: a case report	12
Exploratory use of romosozumab for osteoporosis in a patient with Hajdu–Cheney syndrome: a case report	12
Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis	12
Performance of FRAX in older adults with frailty: the Framingham Heart Study	12
Predictive performance of the Garvan Fracture Risk Calculator: a registry-based cohort study	11

Denosumab-associated symptomatic hypophosphatemia in normal kidney function: two case reports	11
CT image-based biomarkers for opportunistic screening of osteoporotic fractures: a systematic review and meta-analysis	11
Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event	11
Changes in bone mineral density in Down syndrome individuals: a systematic review and meta-analysis	11
No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: a prospective clinical trial	11
The diagnostic value of MRI-based vertebral bone quality score for osteoporosis or osteopenia in patients undergoing lumbar surgery: a meta-analysis	11
Physical function and physical activity in adults with X-linked hypophosphatemia	11
Patients’ preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study	11
Trends in serum phosphate, calcium, and parathyroid hormone levels according to renal function following denosumab	11
The Capture the Fracture® Partnership: an overview of a global initiative to increase the secondary fracture prevention care for patient benefit	11
Opportunistic assessment of osteoporosis using hip and pelvic X-rays with OsteoSight™: validation of an AI-based tool in a US population	11
Impact of switching from bisphosphonates to denosumab, teriparatide, or romosozumab in patients with postmenopausal osteoporosis: a case–control study	11
B vitamins and bone health: a meta-analysis with trial sequential analysis of randomized controlled trials	11
Incidence of hip fractures in Mexico 2006–2019: increasing numbers but decreasing rates	11
Effect of osteoporosis medications on vascular and valvular calcification: a systematic review and meta-analysis	11
Trabecular bone mineral density as measured by thoracic vertebrae predicts incident hip and vertebral fractures: the multi-ethnic study of atherosclerosis	11
Osteoporosis related to WNT1 variants: a not infrequent cause of osteoporosis	11
Examining effects of habitual physical activity and body composition on bone structure in early post-menopausal women: a pQCT analysis	10
Bisphosphonate treatment is associated with decreased mortality rates in patients after osteoporotic vertebral fracture	10
Establishing a Chinese older hip fracture registry for older patients: a Delphi study to define the focus and key variables for this registry	10
Patients with periprosthetic femoral fractures are older adults who are commonly diagnosed with osteoporosis	10
Association of atypical femoral fracture location and lower limb mechanical axis: a computed tomography-based finite element analysis	10
Correction: Risk of major osteoporotic fractures among ultra-orthodox Jews	10
Appropriate dosing of burosumab in tumor-induced osteomalacia	10
Vertebral fracture severity assessment on anteroposterior radiographs with a new semi-quantitative technique	10
Is it important to achieve physical activity recommendations at early stages of life to improve bone health?	10
FRAX-based intervention thresholds for Pakistan	10
Standardized 25(OH)D and fall risk: overcoming challenges and enhancing clinical applications	10
Treatment of glucocorticoid-induced osteoporosis with concurrent denosumab and romosozumab: a case report	10
Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020	10
The pattern of incident fractures according to fracture site in people with T1D	10
Bridging the gap: enhancing osteoporosis management through AI-driven predictive models	10
One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data	10
Development of a novel method to measure bone marrow fat fraction in older women using high-resolution peripheral quantitative computed tomography	10
An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures	10
Effect of postural alignment alteration with age on vertebral strength	10
Commentary on the Broader Perspectives of Hip Fractures in Primary Aldosteronism: From Medical to Social	10
Reply to comments on “Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis”	10
The imminent risk of a fracture—existing worldwide data: a systematic review and meta-analysis	9
DXA-based bone strain index in normocalcemic primary hyperparathyroidism	9
Gender differences in osteoporosis	9
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Plenary Lecture Abstracts	9
Correction to: Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up	9
Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment	9
Addressing the global burden of vitamin D deficiency: insights, challenges, and the need for personalized supplementation	9
Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK	9
Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report	9
Systematic review and meta-analysis of preoperative predictors for early mortality following hip fracture surgery	9
Vitamin B6 challenge as a tool for detecting ALPL mutations and diagnosing hypophosphatasia	9
FREM predicts 10-year incident fracture risk independent of FRAX® probability: a registry-based cohort study	9
IOF position on scientists and societies operating in conflict zones	9
RE: Advanced 2D image processing technique to predict hip fracture risk in an older population based on single DXA scans	9
Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis	9
Magnesium exposure increases hip fracture risks in patients with chronic kidney disease: a population-based nested case–control study	9
Secular trend of humeral fractures incidence rates in patients ≥ 50 years requiring hospitalization: a retrospective analysis of the public health system data in Brazil from 2004 to 2013	9
Management of osteoporosis in patients with chronic kidney disease	9
Association between total and animal proteins with risk of fracture: A systematic review and dose–response meta-analysis of cohort studies	9
Fragility fracture patients with a history of prior fractures more likely to present with multiple risk factors: findings from a province-wide fracture liaison service	9
IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference : Poster Abstracts	9
Author response to: OSIN-D-25–00317, “Comment on: The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population”	9
Correction to: Artificial intelligence-enhanced opportunistic screening of osteoporosis in CT scan: a scoping Review	8
Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis	8
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): SICOT-ESCEO-IOF Symposium Abstracts	8
Pharmacist interventions in osteoporosis management: a systematic review	8
Diagnostic performance of radiomics for predicting osteoporosis in adults: a systematic review and meta-analysis	8
Selection for treatment of patients at high risk of fracture by the short versus long term prediction models — data from the Belgian FRISBEE cohort	8
Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX	8
The significance of recent fracture location for imminent risk of hip and vertebral fractures—a nationwide cohort study on older adults in Sweden	8
Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017–2018	8
Trends in incidence of recorded diagnosis of osteoporosis, osteopenia, and fragility fractures in people aged 50 years and above: retrospective cohort study using UK primary care data	8
No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study	8
Promising diagnostic performance of CBCT-based TOMOSTEOp algorithm in osteoporosis: toward a complementary populational screening tool managed by dentists?	8
Effect of 6-month high-impact step aerobics and resistance training on BMD and tibial bending strength in sedentary premenopausal women	8
Adjusting conventional FRAX estimates of fracture probability according to the number of prior fractures	8
The clinician’s guide to prevention and treatment of osteoporosis	8
Effect of yoga on balance, falls, and bone metabolism: a systematic review of randomized controlled trials in healthy individuals	8
Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness–adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-labe	8
Protein intake and bone health: an umbrella review of systematic reviews for the evidence-based guideline of the German Nutrition Society	8
Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy:	8
Osteoporosis and the long-term risk of peripheral artery disease: a population-based longitudinal follow-up study in Taiwan	8
A cost-consequence analysis of a community-based rehabilitation programme following hip fracture (Fracture in the Elderly Multidisciplinary Rehabilitation—FEMuR III)	8
Outcomes post fragility fracture among members of an integrated healthcare organization	8
Reference data and calculators for second-generation HR-pQCT measures of the radius and tibia at anatomically standardized regions in White adults	8
Comments on “Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up”	8
Pubertal increment in insulin resistance is negatively related to lumbar bone mineral density in 18-year-old males	8
Time trend analysis of osteoporosis prevalence among adults 50 years of age and older in the USA, 2005–2018	8
Longitudinal assessment of physical function in adults with X-linked hypophosphatemia following initiation of burosumab therapy	8
Determining the pharmacologic window of bisphosphonates that mitigates severe injury-induced osteoporosis and muscle calcification, while preserving fracture repair	8
The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population	8
Evidence-based joint statement position of perioperative bone optimization in the arthroplasty candidate, from FEMECOT, AMMOM, ACOMM, SCCOT, SECOT, SEFRAOS, SEIOMM	8
Bone microstructure and TBS in diabetes: what have we learned? A narrative review	8
Fear-avoidant beliefs and behaviours after upper limb fracture in older people: a systematic review and meta-ethnography	8
The rise and fall of raloxifene use for osteoporosis, 1999–2022	8
The effectiveness and cost-effectiveness of clinical fracture-risk assessment tools in reducing future osteoporotic fractures among older adults: a structured scoping review	8
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Satellite Sponsored Symposium Abstracts	7